Tag: Favipiravir
BDR Receives DCGI Approval for Favipiravir to Treat COVID-19
MUMBAI: BDR Pharmaceuticals –today announced the launch of Favipiravir for the treatment of COVID-19 patients.
Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir
KOCHI: Glenmark Pharmaceuticals Ltd. – a global research-led pharmaceutical company – today announced top-line results.
Glenmark Commences 1000 Patients Post Marketing Surveillance Study with COVID-19
KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced.
Glenmark to Commence Phase 3 Clinical Trial for Moderate COVID-19 in India
KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced a new randomized, open-label.